What is the NCSP?
The National Chlamydia Screening Programme (NCSP) in England was established in 2003 with the objective of controlling chlamydia through the early detection and treatment of asymptomatic infection, thus preventing the development of sequelae and reducing onward disease transmission.

Genital Chlamydia trachomatis infection is the sexually transmitted infection diagnosed most frequently in English genitourinary medicine (GUM) clinics. Prevalence of infection is highest in young sexually active adults, especially those aged under 25 years. Untreated infection can have serious long-term consequences, particularly for women, in whom it can lead to pelvic inflammatory disease (PID), ectopic pregnancy and tubal factor infertility. In men it can result in urethritis and epidydimitis and in both men and women it may lead to arthritis. Since many infections are asymptomatic, a large proportion of cases remain undiagnosed, although infection can be diagnosed easily and effectively treated.

There is no evidence to suggest that chlamydia causes cervical cancer.

Be proactive
The National Chlamydia Screening Programme (NCSP) is a control and prevention programme targeted at the highest risk group for chlamydia infection in England, young people under 25 who are sexually active.

Chlamydia is often asymptomatic so a large proportion of cases remain undiagnosed, but infection can be diagnosed easily (young people can do the test themselves), and treated effectively.

To find your local Chlamydia Screening Office or to register with us enter your post code or select your region on the map

uk map North West North East Yorkshire and Humber East Midlands West Midlands East of England South West South Central London South East
Please enter full postcode: